China, Oct. 27 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The Role of Epstein-Barr Virus in the Pathogenesis, Progression, and Therapeutic Response of Systemic Lupus Erythematosus'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135175
Registration Time: 2026/10/26
Type: Observational study
Primary Sponsor: Second Xiangya Hospital of CSU
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=335406
Published by HT Digital Content Services with permission from Health Daily Digest....